Neurontin

Product NDC: 58151-290
11-digit product format: 581510290
Labeler code: 58151
Product ID: 58151-290_2d43f32d-2d96-4011-84ac-507c3307dc27
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: gabapentin
Dosage form: SOLUTION
Route: ORAL
Labeler: Viatris Specialty LLC
Application: NDA021129
Marketing category: NDA
Marketing start: 2026-01-14
Marketing end: 2027-05-31
Substance: GABAPENTIN
Active strength: 250 mg/5mL
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021129-001	NEURONTIN	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N021129-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-09-29 23:25 UTC	2022-09	N021129-001	AA	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021129-001	AA	1	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N021129-001	AA	1	`a50c72e98297…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021129-001	7256216	2022-05-28	Drug product	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021129-001	7256216	2022-05-28	Drug product	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021129-001	7256216	2022-05-28	Drug product	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021129-001	7256216	2022-05-28	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021129-001	7256216	2022-05-28	Drug product	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021129-001	7256216	2022-05-28	Drug product	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021129-001	7256216	2022-05-28	Drug product	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021129-001	7256216	2022-05-28	Drug product	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021129-001	7256216	2022-05-28	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021129-001	7256216	2022-05-28	Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021129-001	7256216	2022-05-28	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021129-001	7256216	2022-05-28	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021129-001	7256216	2022-05-28	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`ea99ee380514…`
2023-01-26 05:58 UTC	2023-01	N021129-001	7256216	2022-05-28	Drug product	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021129-001	7256216	2022-05-28	Drug product	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021129-001	7256216	2022-05-28	Drug product	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021129-001	7256216	2022-05-28	Drug product	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021129-001	7256216	2022-05-28	Drug product	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`cb3db0bc1861…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Neurontin

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	250 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 12 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
105028	Internal RxNorm lookup
105029	Internal RxNorm lookup
105030	Internal RxNorm lookup
261280	Internal RxNorm lookup
261281	Internal RxNorm lookup
283523	Internal RxNorm lookup
310430	Internal RxNorm lookup
310431	Internal RxNorm lookup
310432	Internal RxNorm lookup
310433	Internal RxNorm lookup
310434	Internal RxNorm lookup
351973	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
97935fd9-1d4a-43b6-a5d9-de994591187b	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
58151-290-35	Neurontin	1 in 1 CARTON	SOLUTION	1		47
58151-290-35	Neurontin	470 mL in 1 BOTTLE	SOLUTION	470		47

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
58151-290-35	ML - Milliliter	58151-290	a3e8840b-5328-4ecf-abf2-465a80252594	1	2026-02-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
58151-290	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [VIATRIS SPECIALTY LLC]	41	Current NDC, 2 package rows	20250521_97935fd9-1d4a-43b6-a5d9-de994591187b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Neurontin	GABAPENTIN	Viatris Specialty LLC	97935fd9-1d4a-43b6-a5d9-de994591187b	2026-05-12	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021129 application number: NDA021129 ndc (product): 58151-290
GABAPENTIN	GABAPENTIN	Mylan Pharmaceuticals Inc.	cff7de45-148b-4e96-88fd-6052bf75b5f7	2025-04-12	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021129 application number: NDA021129
Neurontin	GABAPENTIN	Parke-Davis Div of Pfizer Inc	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	2022-07-12	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021129 application number: NDA021129

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310430	gabapentin 100 MG Oral Capsule	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
283523	gabapentin 250 MG in 5 mL Oral Solution	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
310431	gabapentin 300 MG Oral Capsule	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
310432	gabapentin 400 MG Oral Capsule	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
310433	gabapentin 600 MG Oral Tablet	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
310434	gabapentin 800 MG Oral Tablet	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
105028	Neurontin 100 MG Oral Capsule	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
351973	Neurontin 250 MG in 5 mL Oral Solution	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
105029	Neurontin 300 MG Oral Capsule	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
105030	Neurontin 400 MG Oral Capsule	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
261280	Neurontin 600 MG Oral Tablet	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
261281	Neurontin 800 MG Oral Tablet	PSN	97935fd9-1d4a-43b6-a5d9-de994591187b	47
105028	gabapentin 100 MG Oral Capsule [Neurontin]	SBD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
105029	gabapentin 300 MG Oral Capsule [Neurontin]	SBD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
105030	gabapentin 400 MG Oral Capsule [Neurontin]	SBD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
351973	gabapentin 50 MG/ML Oral Solution [Neurontin]	SBD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
261280	gabapentin 600 MG Oral Tablet [Neurontin]	SBD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
261281	gabapentin 800 MG Oral Tablet [Neurontin]	SBD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
310430	gabapentin 100 MG Oral Capsule	SCD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
310431	gabapentin 300 MG Oral Capsule	SCD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
310432	gabapentin 400 MG Oral Capsule	SCD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
283523	gabapentin 50 MG/ML Oral Solution	SCD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
310433	gabapentin 600 MG Oral Tablet	SCD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
310434	gabapentin 800 MG Oral Tablet	SCD	97935fd9-1d4a-43b6-a5d9-de994591187b	47
283523	gabapentin 250 MG per 5 ML Oral Solution	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47
283523	gabapentin 300 MG per 6 ML Oral Solution	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47
283523	gabapentin 500 MG per 10 ML Oral Solution	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47
105028	Neurontin 100 MG Oral Capsule	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47
351973	Neurontin 250 MG per 5 ML Oral Solution	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47
105029	Neurontin 300 MG Oral Capsule	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47
105030	Neurontin 400 MG Oral Capsule	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47
351973	Neurontin 50 MG/ML Oral Solution	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47
261280	Neurontin 600 MG Oral Tablet	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47
261281	Neurontin 800 MG Oral Tablet	SY	97935fd9-1d4a-43b6-a5d9-de994591187b	47

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
58151-290-35	58151029035	1 BOTTLE in 1 CARTON (58151-290-35) / 470 mL in 1 BOTTLE	1 bottle	2026-01-14	2027-05-31	No	No	Historical